ALACHUA, Fla., Feb. 9 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. , a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, today announced the introduction of an additional tissue product for use in their rapidly growing dental business. The product, called Puros Pericardium Allograft Membrane, will address the needs of oral surgeons, periodontists and dentists in conjunction with bone grafting and implant procedures, by offering an excellent healing environment. Tutogen signed an exclusive distribution agreement with its current partner in the dental business, Zimmer Dental.
Guy L. Mayer, CEO of Tutogen Medical said, “We have been extremely pleased with the efforts of our partner, Zimmer Dental, and the excellent clinical performance of our Puros bone products. We are now able to provide a complete biologic approach to clinicians. We believe that the global opportunity for this product could be significant and we are excited about adding a new leading-edge product to our dental segment with an eye toward continuing our explosive growth in this business.”
Mr. Mayer continued, “This expansion to our Regenerative Product line provides our customer the tools necessary for the completion of a total procedure, including preparation to final restoration. Zimmer’s education and marketing programs to the professional dental community will be a significant catalyst in driving the adoption of this new product as well as continuing to expand the Puros product family sales.”
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company’s Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and other international markets. For more information, visit the Company’s Web site at http://www.tutogen.com.
Forward-Looking Statement Disclaimer: Certain statements in this news release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, which may differ materially from those set forth in these statements. In addition, the economic, competitive, governmental, technological and other factors identified in the Company’s filings with the Securities and Exchange Commission could affect such results.
Contacts: Bob Johnston Chief Financial Officer Lytham Partners, LLC Tutogen Medical, Inc. Institutional: Joe Diaz 386-462-0402 ext. 109 Retail: Joe Dorame bjohnston@tutogen.com 602-889-9700
Tutogen Medical, Inc.
CONTACT: Bob Johnston, Chief Financial Officer of Tutogen Medical, Inc.,+1-386-462-0402, ext. 109, bjohnston@tutogen.com; or Institutional, JoeDiaz, or Retail, Joe Dorame, both of Lytham Partners, LLC, +1-602-889-9700,for Tutogen Medical, Inc.
Web site: http://www.tutogen.com/